CSIMarket


Revolution Medicines Inc   (NASDAQ: RVMD)
Other Ticker:  
 

Revolution Medicines Inc

RVMD's Fundamental analysis








Revolution Medicines Inc 's sales fell in III. Quarter 2024 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.29 %

Revolution Medicines Inc net loss increased from $-108 millions, to $-156 millions in III. Quarter 2024,

More on RVMD's Growth


Revolution Medicines Inc
realized a net loss in trailing twelve months.

Revolution Medicines Inc realized cash reduction of $ -0.94 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 9291.1.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.63.


More on RVMD's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 8.96

Revolution Medicines Inc
realized net loss in trailing twelve months.

Revolution Medicines Inc realized cash outflow of $ -0.94per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 9291.1.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.63.

Revolution Medicines Inc Price to Book Ratio is at 4.4 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.02

More on RVMD's Valuation

  Market Capitalization (Millions $) 6,894
  Shares Outstanding (Millions) 167
  Employees 170
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -567
  Cash Flow (TTM) (Millions $) -157
  Capital Exp. (TTM) (Millions $) -11
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 8.96

  Market Capitalization (Millions $) 6,894
  Shares Outstanding (Millions) 167
  Employees 170
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -567
  Cash Flow (TTM) (Millions $) -157
  Capital Exp. (TTM) (Millions $) -11





  Ratio
   Capital Ratio (MRQ) 64.57
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.07
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com